Dear Colleague:

The Melanoma Research Alliance (MRA) is pleased to announce a Second Release of its Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, staging, and treatment.

This Second Release includes two new Special Opportunity awards focused on Melanoma Brain Metastasis, in partnership with the Rising Tide Foundation for Clinical Cancer Research.

The 2020 - 2021 award cycle, is anticipated to support at least $7.6 million in new funding. Proposals will be accepted for Established Investigator, Academic-Industry Partnership, Young Investigator, and Pilot Awards. Other Special Opportunities include awards focused on Immunotherapy, Radiation Oncology, Pediatric Melanoma, and for researchers in the UK and Israel.

MRA encourages applications from a diverse pool of investigators. Full descriptions of each award opportunity offered, including all Special Opportunity Awards, as well as eligibility criteria and instructions can be found on the MRA website at CureMelanoma.org/RFP

Please note the following key deadlines:
•    October 21, 2020: Young Investigator Award Eligibility Checklist Due
•    November 4, 2020: Full Proposals Due for all Award Mechanisms

All proposals are due by 5:00 pm Eastern Time. Proposals should be submitted via the proposalCENTRAL online application tool: https://proposalcentral.com/.

We strongly encourage you to share this RFP with your colleagues in the U.S. and abroad who might want to apply for funding. Please also inform us of others who might not be on our email list who should receive this announcement.

We are happy to answer any questions and good luck!

Sincerely,

Marc Hurlbert, Ph.D.

Chief Science Officer

Kristen Mueller, Ph.D.

Scientific Program Director